NCT05075642 Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis Status UNKNOWN Phase N/A
NCT05075499 Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab Status UNKNOWN Phase NA
NCT05073731 Telerehabilitation-based Upper Extremity Training in People With Multiple Sclerosis Status UNKNOWN Phase NA
NCT05072691 Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis Status RECRUITING Phase N/A
NCT05070286 Lifestyle Weight Management Program: Interviews and Stakeholder Meetings. Status UNKNOWN Phase N/A
NCT05063708 Neuromuscular Electrostimulation in Multiple Sclerosis People With Dysphagia Status COMPLETED Phase NA
NCT05061953 Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis Status RECRUITING Phase N/A
NCT05057338 Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study Status UNKNOWN Phase NA
NCT05054140 Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05051618 Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis Status RECRUITING Phase NA
NCT05046535 The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis Status COMPLETED Phase N/A
NCT05033782 Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis Status COMPLETED Phase N/A
NCT05029609 Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS Status WITHDRAWN Phase PHASE1
NCT05029206 Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden Status COMPLETED Phase N/A